Results 381 to 390 of about 256,813 (405)

Allogeneic hematopoietic stem cell transplantation in the elderly

Critical Reviews in Oncology/Hematology, 2007
The development of reduced intensity or non-myeloablative conditioning (NST) in preparation for allogeneic stem cell transplantation (SCT) revolutionized the field and led to reconsideration of the dogma of upper age limit that was set up by the transplant centers as an eligibility parameter. Analysis of the literature data showed that NST regimens are
Reuven Or, Igor B. Resnick, Ali Abdul-Hai, Shimon Slavin, Panagiotis Tsirigotis, Michael Y. Shapira   +5 more
openaire   +3 more sources

Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica

Annals of Neurology, 2014
Neuromyelitis optica is a rare neurological autoimmune disorder characterized by a poor prognosis. Immunosuppression can halt disease progression, but some patients are refractory to multiple treatments, experiencing frequent relapses with accumulating disability.
Greco R, BONDANZA , ATTILIO, Vago L, Moiola L, Rossi P, Furlan R, MARTINO , GIANVITO, Radaelli M, Martinelli V, Carbone MR, Lupo Stanghellini MT, Assanelli A, Bernardi M, Corti C, Peccatori J, BONINI , MARIA CHIARA, Vezzulli P, FALINI , ANDREA, CICERI , FABIO, COMI , GIANCARLO   +19 more
openaire   +4 more sources

Dendritic cells in allogeneic hematopoietic stem cell transplantation

Leukemia & Lymphoma, 2005
In allogeneic hematopoietic stem cell transplantation (SCT), dendritic cells (DCs) as the most potent antigen-presenting cells play a central role in the development of acute and chronic graft-vs-host disease (GVHD), in graft-vs-leukemia or -malignancy reactions and in fighting infectious complications.
B Kircher, D Nachbaur
openaire   +3 more sources

Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia

Transplant Infectious Disease, 2019
Owing to the shortage of hematopoietic stem cells from matched sibling donors (MSD) and matched unrelated donors (MUD), the number of patients undergoing haploidentical allogeneic hematopoietic stem cell transplantation (allo‐HSCT) has rapidly increased.
Cheng-Hsien Lin, Yi-Jiun Su, Chiann-Yi Hsu, Po-nan Wang, C. Teng   +4 more
semanticscholar   +1 more source

Clinical tolerance in allogeneic hematopoietic stem cell transplantation

Immunological Reviews, 2011
Summary:  Allogeneic hematopoietic stem cell transplantation (HSCT) has been a curative therapeutic option for a wide range of immune hematologic malignant and non‐malignant disorders including genetic diseases and inborn errors. Once in the host, allogeneic transplanted cells have not only to ensure myeloid repopulation and immunological ...
RONCAROLO , MARIA GRAZIA, Gregori S, Lucarelli B, CICERI, FABIO, Bacchetta R.   +4 more
openaire   +4 more sources

Immune Suppression in Allogeneic Hematopoietic Stem Cell Transplantation

2021
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for high-risk hematologic disorders. There are multiple immune-mediated complications following allo-HSCT that are prevented and/or treated by immunosuppressive agents.
Thomas F. Michniacki, Sung Won Choi, Daniel Peltier   +2 more
openaire   +3 more sources

Malakoplakia After Allogeneic Hematopoietic Stem Cell Transplantation

Oncology Nursing Forum, 2015
A 32-year-old woman named A.C. was diagnosed five years ago with stage IIIB nodular sclerosing Hodgkin lymphoma (HL). Following initial chemotherapy, she had refractory disease as evidenced by hypermetabolic activity on positron-emission tomography (PET) scan. A.C.
Tracy Robinson, Erin Streu
openaire   +3 more sources

Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita

Current Opinion in Hematology, 2016
Purpose of reviewDyskeratosis congenita is an inherited bone marrow failure syndrome caused by defects in telomere maintenance. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for bone marrow failure because of dyskeratosis congenita.
Shaimaa Elmahadi, Hideki Muramatsu, Seiji Kojima   +2 more
openaire   +3 more sources

Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis.

Blood, 2009
Abstract Abstract 2283 Poster Board II-260 Background: Reduced intensity allogeneic transplantation was developed to harness graft versus leukemia immune effect to treat older patients and patients with comorbidities who are not eligible for conventional myeloablative ...
Issa F. Khouri, Yago Nieto, Gabriela Rondon, Stefan O. Ciurea, Borje S. Andersson, Roy B. Jones, Richard E. Champlin, Paolo Anderlini, Partow Kebriaei, Marcos de Lima, Chitra Hosing, Sergio Giralt, Muzaffar H. Qazilbash, Amin M. Alousi, Uday R. Popat   +14 more
openaire   +2 more sources

Recent advances in allogeneic hematopoietic stem-cell transplantation

Journal of Laboratory and Clinical Medicine, 2003
Abbreviations: ABM activated bone marrow; alloBMT allogeneic bone-marrow transplantation; APC antigenpresenting cell; BM bone marrow; CML chronic myelogenous leukemia; CMV cytomegalovirus; DC dendritic cell; DLI donor-lymphocyte infusion; EBV Epstein-Barr virus; GCSF granulocyte colony–stimulating factor; GMCSF granulocyte-macrophage colony–stimulating
Ravi Vij, William Blum, R Brown, Steven M. Devine, H Khoury, John F. DiPersio, Douglas Adkins   +6 more
openaire   +2 more sources